Tactogen
Tactogen is a public benefit corporation and pharmatech company focused on developing next-generation mental wellness medicines. They utilize machine learning and targeted assays to identify promising new small molecules for conditions such as anxiety, depression, and stress-related disorders. Their approach emphasizes creating medicines that are safer, more effective, and more accessible than current treatments, with a particular focus on entactogens that facilitate psychotherapy and personal growth with fewer side effects. Tactogen has a strong intellectual property portfolio, including a U.S. patent for novel MDMA derivatives, and aims to make transformative medicines widely available.
Tactogen
Tactogen is a public benefit corporation and pharmatech company focused on developing next-generation mental wellness medicines. They utilize machine learning and targeted assays to identify promising new small molecules for conditions such as anxiety, depression, and stress-related disorders. Their approach emphasizes creating medicines that are safer, more effective, and more accessible than current treatments, with a particular focus on entactogens that facilitate psychotherapy and personal growth with fewer side effects. Tactogen has a strong intellectual property portfolio, including a U.S. patent for novel MDMA derivatives, and aims to make transformative medicines widely available.